G Schettini Selected Research

G Schettini Research Topics

Disease

4	Alzheimer Disease (Alzheimer's Disease) 01/2010 - 06/2000
4	Prion Diseases (Transmissible Spongiform Encephalopathies) 04/2006 - 08/2000
4	Gliosis 02/2004 - 07/2000
3	Inflammation (Inflammations) 02/2004 - 12/2001
3	Breast Neoplasms (Breast Cancer) 01/2004 - 02/2002
3	Neoplasms (Cancer) 10/2003 - 12/2001
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2003 - 07/2002
2	Down Syndrome (Down's Syndrome) 08/2003 - 02/2001
2	Kaposi Sarcoma (Kaposi's Sarcoma) 04/2003 - 12/2001
1	Intervertebral Disc Degeneration 06/2010
1	Prostatic Neoplasms (Prostate Cancer) 01/2006
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2006
1	Cysts 01/2004
1	Neuroblastoma 12/2003
1	Cardiotoxicity 08/2003
1	Mood Disorders (Mood Disorder) 08/2003
1	Astrocytoma (Pilocytic Astrocytoma) 07/2002
1	Dementia (Dementias) 10/2001
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2001
1	Neuroinflammatory Diseases 07/2001
1	Fever (Fevers) 07/2001
1	Infections 06/2001
1	Pituitary Neoplasms (Pituitary Adenoma) 07/2000
1	Brain Diseases (Brain Disorder) 07/2000
1	Adenoma (Adenomas) 07/2000
1	Ependymoma 03/2000

Drug/Important Bio-Agent (IBA)

7	Amyloid (Amyloid Fibrils)IBA 01/2010 - 07/2000
6	Proteins (Proteins, Gene)FDA Link 04/2006 - 02/2001
4	Prion ProteinsIBA 04/2006 - 07/2000
3	Amyloid beta-PeptidesIBA 01/2010 - 08/2003
3	Docetaxel (Taxotere)FDA Link 01/2006 - 02/2002
3	Peptides (Polypeptides)IBA 12/2003 - 11/2000
2	Hormones (Hormone)IBA 01/2006 - 07/2001
2	AntioxidantsIBA 02/2004 - 07/2002
2	Epirubicin (Ellence)FDA LinkGeneric 08/2003 - 02/2002
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2003 - 12/2001
2	ChemokinesIBA 07/2001 - 06/2001
1	Protein Isoforms (Isoforms)IBA 04/2006
1	glycerophosphoethanolamineIBA 02/2004
1	Ethanolamine (Colamine)IBA 02/2004
1	Nootropic Agents (Nootropics)IBA 02/2004
1	2,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA 01/2004
1	LignansIBA 01/2004
1	Indicators and Reagents (Reagents)IBA 01/2004
1	p38 Mitogen-Activated Protein KinasesIBA 12/2003
1	Alanine (L-Alanine)FDA Link 12/2003
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2003
1	Proto-Oncogene Proteins c-retIBA 10/2003
1	Trastuzumab (Herceptin)FDA Link 08/2003
1	Complement System Proteins (Complement)IBA 08/2003
1	gamma-Aminobutyric Acid (GABA)IBA 08/2003
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2003
1	AnthracyclinesIBA 08/2003
1	Mitogen-Activated Protein KinasesIBA 04/2003
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2003
1	Pharmaceutical PreparationsIBA 04/2003
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2003
1	Antineoplastic Agents (Antineoplastics)IBA 04/2003
1	Acetaminophen (Paracetamol)FDA LinkGeneric 07/2002
1	NF-kappa B (NF-kB)IBA 12/2001
1	Transcription Factors (Transcription Factor)IBA 12/2001
1	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2001
1	LigandsIBA 06/2001
1	CXCR4 Receptors (CXCR4 Receptor)IBA 06/2001
1	Tyrosine (L-Tyrosine)FDA Link 02/2001
1	Cabergoline FDA LinkGeneric 07/2000
1	PrionsIBA 07/2000
1	Presenilin-1IBA 06/2000

Therapy/Procedure

2	Therapeutics 07/2000 - 03/2000
1	Pedicle Screws 06/2010
1	Renal Dialysis (Hemodialysis) 01/2006
1	Radiotherapy 03/2000